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Abstract
In this study, we developed a new method to stimulate osteogenic differentiation in tissue-nonspecific alkaline phosphatase
(TNAP)-positive cells liberated from human induced pluripotent stem cells (hiPSCs)-derived embryoid bodies (EBs) with 14
days long TGF-b/IGF-1/FGF-2 treatment. TNAP is a marker protein of osteolineage cells. We analyzed and isolated TNAP-
positive and E-cadherin-negative nonepithelial cells by fluorescence-activated cell sorting. Treating the cells with a
combination of transforming growth factor (TGF)-b, insulin-like growth factor (IGF)-1, and fibroblast growth factor (FGF)-2
for 14 days greatly enhanced TNAP expression and maximized expression frequency up to 77.3%. The isolated cells
expressed high levels of osterix, which is an exclusive osteogenic marker. Culturing these TNAP-positive cells in osteoblast
differentiation medium (OBM) led to the expression of runt-related transcription factor 2, type I collagen, bone sialoprotein,
and osteocalcin (OCN). These cells responded to treatment with activated vitamin D3 by upregulating OCN. Furthermore, in
OBM they were capable of generating many mineralized nodules with strong expression of receptor activator of NF-kappaB
ligand and sclerostin (SOST). Real-time RT-PCR showed a significant increase in the expression of osteocyte marker genes,
including SOST, neuropeptide Y, and reelin. Scanning electron microscopy showed dendritic morphology. Examination of
semi-thin toluidine blue-stained sections showed many interconnected dendrites. Thus, TNAP-positive cells cultured in OBM
may eventually become terminally differentiated osteocyte-like cells. In conclusion, treating hiPSCs-derived cells with a
combination of TGF-b, IGF-1, and FGF-2 generated TNAP-positive cells at high frequency. These TNAP-positive cells had a
high osteogenic potential and could terminally differentiate into osteocyte-like cells. The method described here may reveal
new pathways of osteogenesis and provide a novel tool for regenerative medicine and drug development.
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Introduction
The development of new treatment strategies for osteoporosis
and other skeletal tissue diseases has become increasingly
important considering the growing population of elderly people.
Regenerative medicine and the development of new molecular-
targeted agents are aimed at providing novel tools to address these
clinical demands. Induced pluripotent stem cells (iPSCs) have
attracted the attention of basic and clinical researchers since their
establishment because they have the potential to provide useful
tools for regenerative medicine and drug development. Before the
development of iPSCs, human mesenchymal stem cells (hMSCs)
were promising candidates for bone engineering and regeneration,
and many successful studies with these cells have been reported.
However, hMSCs have several limitations. hMSCs obtained from
elderly people are generally low in number, grow slowly, and show
diverse differentiation potentials. Utilization of hMSCs for drug
development is difficult because of their limited proliferative ability
and the poor reproducibility of the method. These problems could
be resolved using human iPSCs (hiPSCs). However, the osteogenic
differentiation of hiPSCs presents numerous problems, including
time-consuming methods, poor reproducibility, and low efficiency.
The designed differentiation of hiPSCs into osteolineage cells
remains difficult and impedes progress. Several reports have
described the directed differentiation of iPSCs or embryonic stem
cells (ESCs) into multipotent progenitors or osteoprogenitors [1,2].
MSCs or MSC-like cells can be obtained from human ESCs by
methods, such as fluorescence-activated cell sorting (FACS) after
embryoid body (EB) formation. These protocols require prolonged
serial passages or multiple cell sorting steps and are labor-
intensive, time-consuming, and generally inefficient [3].
Other skeletal tissues, such as muscles, can also be successfully
generated from hiPSCs [4]. Goudenege et al. reported that hiPSC-
derived MSCs can be efficiently induced to undergo myogenic
differentiation with MYOD1 overexpression [5]. However, these
protocols have low reproducibility, probably because of the
heterogeneous populations of MSCs that are derived from hiPSCs.
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The other potential approach for generating skeletal tissues is to
isolate paraxial mesodermal progenitors, which may differentiate
into myogenic, osteogenic, and chondrogenic tissues [6]. Platelet-
derived growth factor receptor-a-positive and KDR-negative cells
are immature, and thereby can differentiate into multiple types of
tissues. Platelet-derived growth factor receptor-a-positive cells are
partially differentiated and can be directed to differentiate into
osteolineage cells. Tanaka et al. reported that MYOD1 overex-
pression in immature hiPSCs stimulates them to become mature
myocytes with very high efficiency and reproducibility [7]. Their
method provides relatively uniform undifferentiated cells, which
may preclude variation in their differentiation frequency. Their
results suggested that obtaining relatively uniform types of cells as
early as possible may be very important.
We developed a new strategy to purify osteoprogenitors from
EB-derived cells by isolating tissue-nonspecific alkaline phospha-
tase (TNAP)-positive cells using FACS. We found that cells
separated from EBs did not express TNAP immediately after
single-cell separation. They did not express E-cadherin but
expressed relatively high levels of CD90, indicating that they
were not progenitors of liver or bile duct epithelial cells. Treating
the cells with a combination of transforming growth factor (TGF)-
b, insulin-like growth factor (IGF)-1, and fibroblast growth factor
(FGF)-2 greatly enhanced TNAP expression. Furthermore, the
cells began to express high levels of osterix (OSX), which is an
exclusive osteogenic marker. The cells initially expressed low levels
of runt-related transcription factor 2 (RUNX2), and continuous
culture induced high levels of RUNX2, bone sialoprotein (BSP),
type I collagen (COL1A1), and eventually, osteocalcin (OCN). To
the best of our knowledge, these are the first observations of
osteoprogenitors expressing high levels of TNAP and OSX but low
levels of RUNX2 and collagen1a. In general, MSCs in vivo first
express RUNX2, which promotes the expression of several early
osteogenic marker proteins [8]. These RUNX2-expressing precur-
sors then express OSX and induce differentiation of these cells into
mature and functional osteoblasts. Therefore, OSX is a target
molecule of RUNX2. However, in our experiment, OSX may
have functioned as an initial transcription factor to initiate
osteogenesis. We also found that these cells could form multiple
mineralized nodules with multidendritic cells that express high
levels of receptor activator of NF-kappaB ligand (RANKL),
suggesting they can terminally differentiate into osteocyte-like
cells. These cells are easily obtained from iPSCs and are capable of
differentiating into osteocyte-like cells; they responded to treat-
ment with activated vitamin D3 by upregulating OCN, providing
a new clue in the investigation of osteocytes.
Materials and Methods
Cell culture
hiPSCs (line 201B7, Riken Cell Bank, Tsukuba, Japan) [9] were
maintained with SNL76/7 feeder cells [clonally derived from a
mouse fibroblast Sandoz inbred mouse-derived thioguanine-
resistant and ouabain-resistant (STO) cell line transformed with
neomycin resistance and murine LIF genes; American Type
Culture Collection, Manassas, VA, USA] in human ES medium
[Dulbecco’s modified Eagle’s medium: nutrient mixture F-12
(DMEM/F-12) (Invitrogen, Carlsbad, CA, USA) with 20%
knockout serum replacement (Invitrogen) supplemented with 16
nonessential amino acid solution (Chemicon, Temecula, CA,
USA), 2 mM L-glutamine (Chemicon), 1 mM 2-mercaptoethanol
(Wako Pure Chemical Industries Ltd., Osaka, Japan), 1%
penicillin/streptomycin (Invitrogen), and 5 ng/ml human FGF-2
(ReproCELL Inc., Yokohama, Japan)].
EB formation and in vitro differentiation
The differentiation method is shown in Figure 1. hiPSC colonies
were dissociated with a cell scraper and transferred to low-
attachment Petri dishes to generate EBs. EBs were maintained in
suspension culture in human ES medium without FGF-2 for 6
days. EBs were then cultured in human ES medium with 2 mM
thiazovivin without FGF-2 for 1 h at 37uC. After preincubation
with 2 mM thiazovivin, EBs were collected and dissociated in
0.5 mg/ml collagenase type IV (Wako Pure Chemical Industries
Ltd.) for 20 min at 37uC, followed by incubation in 0.05%
trypsin–EDTA (Invitrogen) for 5 min at 37uC. The trypsinized
EBs were seeded onto cell culture dishes at a density of 1.86104
cells/cm2 and cultured in osteoblast differentiation medium
(OBM), which consisted of a-MEM (Invitrogen) supplemented
with 10% FBS, 50 mg/ml L-ascorbic acid (Wako Pure Chemical
Industries Ltd.), 10 mM b-glycerophosphate (Wako Pure Chem-
ical Industries Ltd.), and 10 nM dexamethasone (Wako Pure
Chemical Industries Ltd.). Various combinations of cytokines
[25 ng/ml FGF-2, 1 ng/ml TGF-b1 (Wako Pure Chemical
Industries Ltd.), 100 ng/ml IGF-1 (Wako Pure Chemical Indus-
tries Ltd.), and 50 ng/ml bone morphogenetic protein (BMP)-2/-7
(R&D Systems, Minneapolis, MN, USA)] were added on the
following day (day 0) and cultured for 14 days. OBM containing
fresh cytokines was resupplied every 3 days. Human periodontal
ligament cells (HPDLCs; Lonza, Basal, Switzerland) were cultured
in OBM for 5 days. We previously reported that HPDLCs could
differentiate into osteogenic cells by culturing in OBM [10].
Alkaline phosphatase (ALP) activity staining
Two weeks after stimulation, the cells were washed two times
with phosphate-buffered saline (PBS), fixed in 4% paraformalde-
hyde for 5 min at room temperature, and washed three times with
water. For staining, an ALP substrate solution (Roche Diagnostics,
Basel, Switzerland) was added to the fixed cells for 60 min at room
temperature. After staining, the cells were washed three times with
distilled water, and the images were analyzed.
Antibodies, cell staining, flow cytometric analysis, and
cell sorting
After 2 weeks of osteogenic differentiation, cells from hiPSC-
derived EBs that had differentiated in culture in OBM were
trypsinized with 0.05% trypsin–EDTA for 10 min at 37uC. The
trypsinized cells were stained with anti-human ALP phycoery-
thrin-conjugated antibody (R&D Systems) for 45 min on ice in the
dark. After staining, the cells were washed three times with PBS,
suspended in PBS containing 0.5% FBS, passed through a 40- mm
mesh filter, and maintained at 4uC until flow cytometric analysis
and cell sorting. Dead cells were excluded from flow cytometric
analysis on the basis of propidium iodide staining (2 mg/ml) and
forward scatter. We used a FACSAria (Becton-Dickinson, San
Jose, CA, USA) which is a high speed cell sorter for measuring and
sorting fluorescently labeled cells. Because a FACSAria is
compatible with analyzing and sorting cells at the same time, we
used a FACSAria to sort TNAP-positive cells. These TNAP-
positive cells were found in cells cultured for 14 days in OBM
supplemented with TGF-b, IGF-1, and FGF-2. After this
cultivation in OBM, we sorted TNAP-positive cells by FACS.
RNA isolation and reverse transcription gene expression
Reverse transcription-polymerase chain reaction (RT-PCR) was
used to examine the expression of ALP isozymes and osteocyte
markers. Real-time RT-PCR (qRT-PCR) was used to examine the
expression of markers of ES cells, osteoblasts, and osteocytes. Total
Osteoprogenitor Cells from hiPSCs Express High OSX and Low RUNX2
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RNA was extracted using QIAzol reagent (Qiagen Inc., Valencia,
CA, USA) according to the manufacturer’s instructions. cDNA
was synthesized using a high-capacity cDNA reverse transcription
kit (Applied Biosystems, Foster City, CA, USA). RT-PCR was
performed with GoTaq DNA polymerase (Promega, Madison,
WI, USA). Target genes were germ cell-specific ALP (GCAP),
placenta-specific ALP (PLAP), intestine-specific ALP (IAP), tissue-
nonspecific ALP (TNAP), dentin matrix protein 1 (DMP1), FGF23,
phosphate regulating endopeptidase homolog X-linked (PHEX),
matrix extracellular phosphoglycoprotein (MEPE), and podopla-
nin (PDPN). Beta-actin (b-actin) was used as an internal control.
The primers for these genes are described in Table 1. qRT-PCR
was performed using the Premix Ex Taq reagent (Takara Bio Inc.,
Shiga, Japan) according to the manufacturer’s instructions. Target
genes were OCT3/4, SOX2, NANOG, REX1, ESG1, telomerase
reverse transcriptase (TERT), RUNX2, TNAP, BSP, COL1A1, OSX,
OCN, sclerostin (SOST), reelin (RELN), and neuropeptide Y (NPY).
Glyceraldehyde phosphate dehydrogenase (GAPDH) or 18S rRNA
was used as an internal control. All primers and probes are
presented in Table 2 and were designed using Probefinder v2.49
(https://qpcr.probefinder.com/organism.jsp). Relative expression
of genes of interest was estimated using the DDCt method.
Histochemistry for osteogenesis
Alizarin Red staining was performed as described previously
[10]. In brief, the cultured cells were fixed with 4% paraformal-
dehyde in PBS for 5 min at room temperature, washed two times
in PBS, incubated in Alizarin Red S solution for 5 min at room
temperature, and washed five times in PBS at room temperature.
Images were captured using a phase-contrast microscope.
Immunohistochemistry
The cells were fixed with 4% paraformaldehyde in PBS for 1 h.
After washing, nonspecific binding of antibodies was blocked with
5% BSA in Tris-buffered saline with 0.05% Tween 20 (TBST,
pH 7.6) at room temperature for 1 h. The cells were incubated
with the primary antibody in TBST containing 5% BSA for
overnight at 4uC (1:100 for goat anti-RANKL and 1:50 for rabbit
anti-SOST; both from Santa Cruz Biotechnology, Dallas, TX,
USA). The secondary antibodies were fluorescein isothiocyanate-
conjugated anti-goat IgG (1:200; Santa Cruz Biotechnology) and
fluorescein isothiocyanate-conjugated anti-rabbit IgG (1:200;
Zymed Laboratories, South San Francisco, CA, USA). The
secondary antibodies were diluted in TBST and the cells were
incubated for 1 h in the dark. The cells were finally stained with
DAPI for nuclear staining.
Figure 1. Schematic representation of the protocol for differentiation of hiPSCs into osteoblast-like cells. EBs were prepared by
culturing on low-attachment Petri dishes for 6 days and dissociated in 0.5 mg/ml collagenase type IV and 0.05% trypsin–EDTA. The trypsinized EBs
were cultured in OBM on cell culture dishes. Next day, various cytokines were added to the dishes (day 0) and the OBM containing cytokines was
changed every 3 days. After 14 days, the cells were analyzed and isolated by FACS.
doi:10.1371/journal.pone.0099534.g001
Table 1. Primers used for RT-PCR.
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Electron microscopy
For scanning electron microscopy (SEM), after FACS sorting,
both TNAP-positive and -negative cells were cultured in OBM for
120 days. The cells were fixed in 2.5% glutaraldehyde and 2%
paraformaldehyde in 0.1 M cacodylate buffer, pH 7.4, for
overnight at 4uC. After washing with 0.1 M cacodylate buffer,
the samples were dehydrated in a graded series of ethanol and
immersed in t-butyl alcohol for 30 min at 4uC. Next, the samples
were freeze-dried with an ID-2 freeze dryer (Eiko, Tokyo, Japan)
and sputter-coated with a cool sputter coater (SC500A, VG
Microtech, East Sussex, UK). Finally, the samples were examined
under a scanning electron microscope (SU-6600, Hitachi Co.,
Tokyo, Japan). For transmission electron microscopy (TEM), after
FACS sorting, TNAP-positive cells were cultured in OBM for 120
days. The cells were fixed in 2.5% glutaraldehyde and 2%
paraformaldehyde in 0.1 M cacodylate buffer, pH 7.4, for
overnight at 4uC. After washing with 0.1 M cacodylate buffer,
the samples were postfixed with 1% osmium tetroxide in
cacodylate buffer for 1 h at room temperature. The samples were
then dehydrated and embedded in epoxy resin (Epon 812, Taab,
Aldermaston, UK) for thin sectioning. Semi-thin sections were
stained with toluidine blue for light microscopy. Thin sections
were stained with uranyl acetate and lead citrate and examined by
TEM (H-7650, Hitachi Co.).
Statistical analysis
Data are expressed as mean 6 S.D. and were analyzed using
ANOVA, the Bonferroni test, or Student’s t-test. All data are
representative of at least three independent experiments. Statistical
significance was defined as p,0.05.
Results
TNAP-positive cells derived from human iPSCs
We induced EBs from hiPSCs and then the trypsinized EBs.
TNAP-positive cells were not observed immediately after trypsinization.
The trypsinized EBs were cultured in OBM with various cytokines.
We investigated which combination of cytokines was most effective
in inducing TNAP-positive cells. The number of TNAP-positive
cells was markedly increased by treatment with a combination of
FGF-2, TGF-b, and IGF-1, and these cells could be isolated using
FACSAria (Fig. 2a, b). ALP isoenzymes are categorized into four
classes: germ cell specific, placenta specific, intestine specific, and
tissue nonspecific. Parental hiPSCs and ALP-positive cells derived
from hiPSCs by EB formation expressed the TNAP isoenzyme,
whereas ALP-negative cells did not express any ALP isoenzyme
(Fig. 2c). Subsequently, TNAP-positive cells were assessed for the
expression of the MSC marker CD90 and the epithelial cell marker
E-cadherin. Almost all cells were also CD90-positive and E-
cadherin-negative (Fig. 2d). As shown in Figure 2e, TNAP-positive
cells were spindle shaped, like MSCs, and TNAP-negative cells were
cuboidal, like epithelial cells. These data suggested that TNAP-
positive cells derived from hiPSCs were not epithelial cells.
TNAP-positive cells expressed various osteoblast marker
genes
We determined the expression of ES cell markers and
osteoblast-specific markers to confirm osteoblast differentiation.
The expression of ES cell markers OCT3/4, SOX2, NANOG,
REX1, ESG1 (DPPA5), and TERT was markedly reduced in both
TNAP-positive and -negative cells compared with hiPSCs (Fig. 3a).
In TNAP-positive cells, we found marked expression of not only
TNAP but also OSX (Fig. 3b). Although the expression of RUNX2
and COL1A1 was relatively low, the expression of the marker for
committed osteoblasts OSX was markedly increased, suggesting
that these cells were osteolineage cells. Compared with TNAP-
negative cells, the expression of the osteoblast-specific markers
TNAP, OSX, BSP, and OCN was markedly upregulated in TNAP-
positive cells cultured in OBM for 40 days (Fig. 3c). The
expression of osteoblast markers RUNX2, COL1A1, and BSP was
markedly increased in TNAP-positive cells when these cells were
cultured for 40 days. In addition, OCN expression showed a
Table 2. Primers used for qRT-PCR.
Gene symbol GenBank accession no. Forward primer sequence Reverse primer sequence
OCT3/4 NM_001173531.1 caatttgccaagctcctga agatggtcgtttggctgaat
SOX2 NM_003106.3 ctccgggacatgatcagc ggtagtgctgggacatgtga
NANOG NM_024865.2 atgcctcacacggagactgt cagggctgtcctgaataagc
REX1 NM_174900.3 ggccttcactctagtagtgctca ctccaggcagtagtgatctgagt
ESG1 NM_001025290.2 cagaggtgttccaggtccag ctcgatgtaagggattcgaga
TERT NM_001193376.1 gccttcaagagccacgtc ccacgaactgtcgcatgt
RUNX2 NM_001024630.2 gtgcctaggcgcatttca gctcttcttactgagagtggaagg
ALP NM_000478.3 caaccctggggaggagac gcattggtgttgtacgtcttg
COL1A1 NM_000088.3 gggattccctggacctaaag ggaacacctcgctctcca
OSX NM_152860.1 catctgcctggctccttg caggggactggagccata
OCN NM_199173.3 tgagagccctcacactcctc acctttgctggactctgcac
SOST NM_025237.2 agctggagaacaacaagacca agctgtactcggacacgtctt
RELN NM_005045.3 tgagagccagcctacagga tcgttccacattctgtaccaa
NPY NM_000905.3 ctcgcccgacagcatagta gccccagtcgcttgttac
GAPDH NM_002046.3 agccacatcgctcagacac gcccaatacgaccaaatcc
18S rRNA M11188.1 cggacaggattgacagattg cgctccaccaactaagaacg
doi:10.1371/journal.pone.0099534.t002
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Figure 2. Characterization of ALP-positive cells derived from human iPSCs. (a) Single cells from hEBs were cultured with various cytokines
for 2 weeks and stained for ALP activity. The cells were cultured in a-MEM containing 10% FBS (a-MEM); a-MEM containing 10% FBS, ascorbic acid,
and b-glycerophosphate (b-GP) (OBM); OBM with FGF-2 and TGF-b1 (FGF2 + TGF); OBM with FGF-2, TGF-b1, and IGF-1 (FGF2 + TGF + IGF); OBM with
FGF-2 and BMP-2/-7 (FGF2 + BMP); or OBM with FGF-2, BMP-2/-7, and IGF-1 (FGF2 + BMP + IGF). The percentages shown indicate the frequency of
ALP-positive cells determined by FACS analysis. (b) FACS analysis for the isolation of ALP-positive cells (right) and isotype control (left). (c) Expression
of ALP isoenzymes: germ cell-specific ALP (G), placenta-specific ALP (P), intestine-specific ALP (I), tissue-nonspecific ALP (T), and b-actin (B) in parental
hiPSCs, isolated ALP-positive cells, and isolated ALP-negative cells. (d) FACS analysis of CD90 and E-cadherin in the TNAP-positive population. (e)
Morphology of TNAP-positive (TNAP+) and TNAP-negative (TNAP2) cells.
doi:10.1371/journal.pone.0099534.g002
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significant increase and TNAP expression showed a decreasing
trend with vitamin D3 treatment (Fig. 3d). These observations
indicated that these cells could respond to osteogenic reagents and
could differentiate into cells in the late phase of osteogenesis.
TNAP-positive cells expressed characteristics of
osteocyte-like cells
After culture in OBM for 40 days, TNAP-positive cells
differentiated into osteocyte-like cells containing an abundant
calcium matrix, as revealed by Alizarin Red-positive staining in
the well (Fig. 4a). In contrast, TNAP-negative cells exhibited no
potential to form calcium-positive osteocytes, as indicated by the
absence of Alizarin Red staining (Fig. 4a). Many mineralized
nodule-like structures were observed in cultures of TNAP-positive
cells but not in those of TNAP-negative cells. In addition, TNAP-
positive cells expressed RANKL in the areas of mineralized
nodule-like structures. The expression of SOST was observed only
in TNAP-positive cells but not in TNAP-negative cells (Fig. 4b).
The expression of osteocyte markers SOST, RELN, and NPY was
significantly increased in TNAP-positive cells (Fig. 4c). The
expression of these osteocyte markers increased concentration-
dependently with vitamin D3 administration only after 6 days in
culture (Fig. 4d). As shown in Figure 4e, expression of the
osteocyte marker genes DMP1, FGF23, and MEPE was detected in
TNAP-positive cells.
Morphology of osteocyte-like cells as observed by
electron microscopy
After culture in OBM for 120 days, many cytoplasmic processes
were observed in TNAP-positive cells (Fig. 5a). In contrast, TNAP-
negative cells were round and had no cytoplasmic processes
(Fig. 5a). Cell–cell contact with a cytoplasmic process was observed
in TNAP-positive cells (Fig. 5b, c, arrowheads).
Figure 3. Characterization of gene expression in TNAP-positive iPSCs. (a) Comparison of expression of ES cell markers in TNAP-negative
(TNAP2) and TNAP-positive (TNAP+) cells. qRT-PCR analysis of OCT3/4, SOX2, NANOG, REX1, ESG1, and TERT was performed in isolated cells using a
FACSAria cell sorter. Parental iPSCs (hiPS) was used as a positive control. (b) Comparison of the expression of markers of osteoblast differentiation in
TNAP-negative (TNAP2) and TNAP-positive (TNAP+) cells. qRT-PCR analysis was performed in cells isolated by FACS. Parental iPSCs (hiPS) were used
as a negative control and osteogenic-differentiated HPDLCs (ODH) as a positive control. (c) qRT-PCR analysis was performed with cells grown in OBM
for 40 days. (d) After isolation by FACS, TNAP-positive cells were treated with vehicle (cont), 10 nM active vitamin D3 (VD10), or 50 nM active vitamin
D3 (VD50) for 6 days. Abbreviations: RUNX2, runt-related transcription factor 2; TNAP, tissue-nonspecific alkaline phosphatase; COL1A1, type I
collagen; OSX, osterix; BSP, bone sialoprotein; OCN, osteocalcin. The expression of these genes was analyzed by qRT-PCR, and the mRNA levels of the
genes were normalized to that of GAPDH or 18S rRNA. The experiments were performed in triplicate. Values represent mean 6 S.D. (n = 4). *p,0.05,
**p,0.01, ***p,0.005.
doi:10.1371/journal.pone.0099534.g003
Osteoprogenitor Cells from hiPSCs Express High OSX and Low RUNX2
PLOS ONE | www.plosone.org 6 June 2014 | Volume 9 | Issue 6 | e99534
Discussion
iPSCs are powerful tools in many fields of basic scientific
research. Several reports have shown that osteogenic cells can be
generated from iPSCs [3,6,7,11–15]. The reported methods for
the generation of osteogenic cells are time-consuming and labor-
intensive and include repeated passages to select fast-growing
adhesive cells [2]. The phenotypic characteristics of these cells are
similar to those of mesenchymal cells. Bilousova et al. [14]
reported that retinoic acid treatment of murine iPSCs cultured in
OBM for several weeks resulted in cells that were positive for
osteogenic markers and Alizarin Red staining. This so-called
outgrowth method essentially requires no supplements other than
OBM. However, human iPSCs are not as simple to differentiate as
murine iPSCs. Multistep, labor-intensive processes are often
necessary. Mahmood et al. [16] reported that iPSCs that were
cultured in low-adhesive plastic Petri dishes with the TGF-b
inhibitor SB-431542 for 10 days formed EBs and adhered to the
cell culture dishes. These cells could be passaged 4–11 times. The
cells were then transferred into OBM and cultured for an
additional 20 days, eventually forming osteoblasts. Villa-Diaz et al.
[3] used synthetic polymer-coated dishes to generate MSCs. It is
possible that these MSCs derived from iPSCs were a mixed
population of cells, although the protocol usually requires a long
period of time. Thus, methods that are simpler and less time-
consuming are desired.
The most essential proteins for mineralization by osteolineage
cells are COL1A1 and ALP [17]. Humans have four ALP genes
encoding intestinal, placental, placenta-like, and liver/bone/
kidney (i.e., TNAP) gene products. TNAP is localized on the
outside of the plasma membrane of cells and in the membrane of
matrix vesicles and is attached to the membrane by a glycopho-
sphatidylinositol anchor. TNAP in osteolineage cells is expressed
relatively early during differentiation and is abundantly expressed
on the membrane surface. Apart from osteolineage cells, epithelial
Figure 4. TNAP-positive cells express various osteocyte markers. (a) Osteogenic differentiation was confirmed by Alizarin Red staining after
40 days in OBM. The upper panels are whole-well images and lower panels are magnified images. (b) Phase-contrast images of TNAP-negative and -
positive cells derived from hiPSCs at day 40 of culture in OBM (upper panel). The black box in the upper images represents the region shown in the
middle and lower images. (c) Comparison of the expression of osteocyte marker genes between TNAP-negative (TNAP2) and TNAP-positive (TNAP+)
cells by qRT-PCR. Osteogenic-differentiated HPDLCs (ODH) were used as a control. (d) TNAP-positive cells were treated with vehicle (white bars),
10 nM vitamin D3 (gray bars), or 50 nM vitamin D3 (black bars) for 6 days. (e) Comparison of expression of osteocyte marker genes between TNAP-
negative (TNAP2) and TNAP-positive (TNAP+) cells by RT-PCR. Abbreviations: SOST, sclerostin; RELN, reelin; NPY, neuropeptide Y. Expression of these
genes was analyzed by qRT-PCR, and mRNA levels of the genes were normalized to that of GAPDH. The experiments were performed in triplicate.
Values represent mean 6 S.D. (n = 4). *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0099534.g004
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cells also express TNAP. Therefore, accumulation of relatively
pure osteolineage cells among TNAP-positive cells will probably
require elimination of epithelial cells. Some cells among EBs
derived from hiPSCs expressed ALP (Fig. 2a, b). RT-PCR clearly
showed that these cells expressed TNAP (Fig. 2c). Morphologi-
cally, TNAP-positive cells were fibroblastic and spindle shaped
rather than cuboidal or epithelial shaped (Fig. 2e). We next
examined whether these cells expressed E-cadherin. Most cells
were E-cadherin-negative and CD90-positive, indicating that
TNAP-positive cells are probably not epithelial cells. We further
investigated methods of maximizing TNAP expression. Previous
reports indicated that activins, retinoic acids, and BMPs are
capable of inducing osteolineage cells from ESCs or iPSCs
[6,13,14]. We attempted several combinations of cytokines and
found that activins, retinoic acids, and BMPs did not effectively
induce TNAP expression (data not shown). However, exposure to
TGF-b, IGF-1, and FGF-2 in OBM had the most potent TNAP-
inducing effects (Fig. 2a). Although the mechanisms by which ALP
expression is regulated are complex, the BMP/Runx2 and Osx
systems are believed to be the principal regulatory pathways
controlling osteoblast differentiation and TNAP expression [8]. In
brief, the BMP/Smad pathway targets activation of Runx2, which
Figure 5. SEM and TEM images of TNAP-positive cells induced to differentiate into osteocyte-like cells. After isolation by FACS, TNAP-
positive and -negative cells were cultured in OBM for 120 days. (a) SEM images of TNAP-negative (TNAP2) and TNAP-positive (TNAP+) cells. (b)
Images of toluidine blue-stained semi-thin sections of TNAP-positive cells are shown at low (left) and high (right) magnification with light microscopy.
(c) TEM image of TNAP-positive cells. Arrowheads indicate cytoplasmic processes.
doi:10.1371/journal.pone.0099534.g005
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in turn activates Osx expression. Because epigenetic conditions
during embryonic development are quite different from those
during ESC/iPSC differentiation, the transcription factors re-
quired for TNAP expression may be different. In embryos, Runx2
is required for the differentiation of prechondrogenic mesenchy-
mal cells into osteoblasts, whereas Osx is believed to induce
subsequent maturation of osteoblasts and inhibit chondrogenic
differentiation. In Osx-null embryos, cartilage forms normally but
the embryos completely lack bone [17–19]. OSX, which is
specifically and exclusively expressed in all osteoblasts, showed
markedly high expression in TNAP-positive cells, although TNAP-
positive and -negative cells expressed almost similar levels of
RUNX2 (Fig. 3b). These findings indicated that iPSCs may not
require the prechondrogenic process and may induce Osx without
a Runx2 surge. Several pathways have been reported to increase
Osx expression. Mitogen-activated protein kinases, particularly
p38, Erk1/2, and protein kinase D, activate Osx expression
accompanied by TNAP activation. Ascorbate-dependent prolyl
hydroxylase domain protein induces Osx expression. Endoplasmic
reticulum stress also increases Osx induction [20]. These cascades
may play an important role in the Osx surge and the increase in
TNAP in iPSCs. We found that continuous culture of these
TNAP-positive cells in OBM eventually led to increased expres-
sion of RUNX2, TNAP, COL1A1, and OSX as well as other
osteogenic markers, such as BSP and OCN. These results indicated
that TNAP-positive cells derived from hiPSCs are OSX-positive
osteoprogenitors, not chondrogenic cells. Furthermore, TNAP-
positive cells are capable not only of differentiating into osteogenic
cells but also of responding to active vitamin D treatment. Vitamin
D treatment effectively upregulated OCN and downregulated
TNAP, indicating that these cells could differentiate into cells in the
late phase of osteogenesis and may be able to differentiate into
terminally differentiated osteocytes.
Previous reports showed that murine and human ESCs cultured
in OBM formed a number of bone/mineralized nodules with
intense mineralization [21,22]. A bone nodule is a group of cells
with three-dimensional multistratified structures. We found that
TNAP-positive cells derived from hiPSCs formed several bone
nodules that contained intensely stained anti-RANKL-immuno-
positive cells (Fig. 4b). We also observed anti-SOST positivity in
these areas (Fig. 4b). qRT-PCR and RT-PCR clearly showed a
significant increase in the expression of osteocyte marker genes,
including SOST, NPY, RELN, DMP1, FGF23, and MEPE (Fig. 4c,
d, and e). SEM showed that TNAP-negative cells had a cuboidal
morphology without dendritic structures, whereas TNAP-positive
cells were flattened with multiple dendritic morphologies after
cultivation in OBM (Fig. 5a). Toluidine blue-stained semi-thin
sections clearly showed that these dendrites were connected to
each other. The osteocyte-like cell line MLO-Y4 shows similar
morphology [23]. Thus, these cells were osteocyte-like cells.
In the present study, formation of bone nodules was observed
much more frequently in iPSCs than in MSCs, similar to the
findings of a previous study [24]. Because ESCs and iPSCs have a
higher proliferative potential, they may form multistratified
structures more readily and thus provide cells with a three-
dimensional microenvironment that promotes terminal differenti-
ation into osteocyte-like cells. Although our cells were positive for
most osteocyte marker proteins, the expression of PHEX was not
increased. This difference may be related to the in vivo
microenvironment.
In conclusion, treating trypsinized single cells with a combina-
tion of TGF-b, IGF-1, and FGF-2 generated TNAP-positive cells
at a high frequency. These TNAP-positive cells had high
osteogenic potential and could terminally differentiate into
osteocyte-like cells. They responded to osteogenic reagents and
may be a useful tool for drug evaluation.
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